NIMG-67. ADVANCED PERFUSION AND DIFFUSION MR IMAGING IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AS FIRST-LINE THERAPY

Por Connelly, Jennifer M, Prah, Melissa A, Schmainda, Kathleen M
Publicado no Neuro Oncol (2017)

Spatial Discrimination of Glioblastoma And Treatment Effect With Histologically-Validated Perfusion And Diffusion Magnetic Resonance Imaging Metrics

Por Prah, Melissa A, Al-Gizawiy, Mona M, Mueller, Wade M, Cochran, Elizabeth J, Hoffmann, Raymond G, Connelly, Jennifer M, Schmainda, Kathleen M
Publicado no J Neurooncol (2017)

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

Por LaViolette, Peter S., Cohen, Alex D., Prah, Melissa A., Rand, Scott D., Connelly, Jennifer, Malkin, Mark. G., Mueller, Wade. M., Schmainda, Kathleen M.
Publicado em 2013

Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network

Por Newitt, David C., Malyarenko, Dariya, Chenevert, Thomas L., Quarles, C. Chad, Bell, Laura, Fedorov, Andriy, Fennessy, Fiona, Jacobs, Michael A., Solaiyappan, Meiyappan, Hectors, Stefanie, Taouli, Bachir, Muzi, Mark, Kinahan, Paul E., Schmainda, Kathleen M., Prah, Melissa A., Taber, Erin N., Kroenke, Christopher, Huang, Wei, Arlinghaus, Lori R., Yankeelov, Thomas E., Cao, Yue, Aryal, Madhava, Yen, Yi-Fen, Kalpathy-Cramer, Jayashree, Shukla-Dave, Amita, Fung, Maggie, Liang, Jiachao, Boss, Michael, Hylton, Nola
Publicado no J Med Imaging (Bellingham) (2017)